Lenalidomide (CC-5013)
S095LEPT01
Phase 1 small_molecule active
Quick answer
Lenalidomide (CC-5013) for Advanced Solid Tumors is a Phase 1 program (small_molecule) at BRIGHT MINDS BIOSCIENCES INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- BRIGHT MINDS BIOSCIENCES INC.
- Indication
- Advanced Solid Tumors
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active